Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Tuesday, April 19<br />
Scientific Platform Sessions<br />
1:00 p.m.–3:00 p.m. Scientific Platform Sessions<br />
S30: Movement Disorders:<br />
Ataxias and Other<br />
Hyperkinetic Movement<br />
Disorders<br />
1:00 p.m. Presentation of the Jon Stolk<br />
Award in Movement Disorders for<br />
Young Investigators<br />
Sponsored by the American Academy<br />
of Neurology and endowed by Kyowa<br />
Pharmaceutical, Inc., Lineberry Research,<br />
Quintiles, and Dr. Dennis Gillings.<br />
Recipient:<br />
Ken Nakamura, MD, PhD<br />
San Francisco, CA<br />
1:15 p.m. S30.002<br />
Identification of Antibodies Against<br />
Inositol 1,4,5-Triphosphate Receptor<br />
1 (IR3R1) in Cerebellar Ataxia<br />
and Primary Progressive Multiple<br />
Sclerosis —Harry Alexopoulos, Penelope<br />
Fouka, Ioanna Chatzi, Skarlatos Dedos,<br />
Martina Samiotaki, George Panayotou,<br />
Panagiotis Politis, Athanasios Tzioufas,<br />
Marinos Dalakas<br />
1:30 p.m. S30.003<br />
Deep Brain Stimulation Placement<br />
Using Intraoperative MRI for Dystonia:<br />
One Year Clinical Outcomes —Vibhash<br />
Sharma, Kushal Naik, Shirley Triche,<br />
Cathrin Buetefisch, Jon Willie, Nicholas<br />
Boulis, Stewart Factor, Robert Gross,<br />
Mahlon DeLong<br />
1:45 p.m. S30.004<br />
Lack of Aprataxin Impairs<br />
Mitochondrial Functions Via<br />
Downregulation of the APE1/NRF1/<br />
NRF2 Pathway —Beatriz Garcia-Diaz,<br />
Emanuele Barca, Andrea Balreira, Luis<br />
Lopez, Saba Tadesse, Sindu Krishna,<br />
Ali Naini, Caterina Mariotti, Barbara<br />
Castellotti, Catarina Quinzii Hirano<br />
2:00 p.m. S30.005<br />
The Core Clinical Features of MTATP6 -<br />
Related Mitochondrial Disease —Mika<br />
Martikainen, Yi Shiau Ng, Grainne Gorman,<br />
Andrew Schaefer, Rita Horvath, Patrick<br />
Chinnery, Emma Blakely, Charlotte Alston,<br />
Robert Taylor, Robert McFarland, Douglas<br />
Turnbull<br />
2:15 p.m. S30.006<br />
Clinical and Neuroradiological<br />
Features of Spinocerebellar Ataxia<br />
38 (SCA38) —Barbara Borroni, Eleonora<br />
Di Gregorio, Laura Orsi, Giovanna Vaula,<br />
Chiara Costanzi, Stefano Gazzina, Filippo<br />
Tempia, Nico Mitro, Donatella Caruso,<br />
Lorenzo Pinessi, Alessandro Padovani,<br />
Alfredo Brusco, Loredana Boccone<br />
2:30 p.m. S30.007<br />
Targeting ATXN2 Using Antisense<br />
Oligonucleotides As a Treatment<br />
for Spinocerebellar Ataxia Type 2<br />
(SCA2) —Daniel Scoles, Matthew<br />
Schneider, Pratap Meera, Karla Figueroa,<br />
Gene Hung, Frank Rigo, Frank Bennett,<br />
Thomas Otis, Stefan Pulst<br />
2:45 p.m. S30.008<br />
Clinical and Genetic Heterogeneity<br />
of Paroxysmal Dyskinesias —Kailash<br />
Bhatia, Roberto Erro, Alice Gardiner, Fatima<br />
Zaheera Jaffer, Maria Stamelou, Matthew<br />
Walker, Dimitri Kullmann, Paul Jarman,<br />
Manju Kurian, Henry Houlden<br />
S31: Stroke Risk, Outcomes, and<br />
Complications<br />
1:00 p.m. Presentation of the Founders<br />
Award<br />
Sponsored by the American Academy of<br />
Neurology and endowed by the former<br />
American Academy of Neurology Alliance.<br />
Recipient:<br />
Michelle P. Lin, MD, MPH<br />
Los Angeles, CA<br />
1:15 p.m. S31.002<br />
Predictors of Dysphagia Screening<br />
After Acute Ischemic Stroke —Raed<br />
Joundi, Rosemary Martino, Gustavo<br />
Saposnik, Jimming Fang, Vasily<br />
Giannakeas, Moira Kapral<br />
1:30 p.m. S31.003<br />
Multiple Myeloma Stage I, II and<br />
Renal Insufficiency Are Associated<br />
with Increased Stroke Risk —Kaustubh<br />
Limaye, Rahul Ravilla, Appalnaidu Sasapu,<br />
Xenofon Papanikolaou, Sarah Waheed,<br />
Archana Hinduja<br />
1:45 p.m. S31.004<br />
The Stroke Nurse Project: A<br />
Community-Based Approach to<br />
Improving the Post-Acute Care of<br />
Stroke Patients —Thomas Staudacher,<br />
Pia Bader, Jürgen Kunz, Dietmar Bengel,<br />
Hans Joachim von Büdingen<br />
2:00 p.m. S31.005<br />
Does Smoking Status Influence the<br />
Effect of Clopidogrel on Secondary<br />
Stroke Prevention? —Bruce Ovbiagele,<br />
Jing Wang, Johnston S. Claiborne, Anxin<br />
Wang, Yongjun Wang, Xingquan Zhao,<br />
Yilong Wang<br />
2:15 p.m. S31.006<br />
Impact of Early Intervention with<br />
OnabotulinumtoxinA Treatment in<br />
Adult Patients with Post-Stroke Lower<br />
Limb Spasticity —Atul Patel, Anthony<br />
Ward, Carolyn Geis, Chengcheng Liu,<br />
Wolfgang Jost, Rozalina Dimitrova<br />
2:30 p.m. S31.007<br />
Atorvastatin Treatment Is Associated<br />
with Increased BDNF Level and<br />
Improved Functional Recovery After<br />
Atherothrombotic Stroke —Jingmiao<br />
Zhang, Xiali Mu, Zongliang Gao, Yonglu<br />
Huang<br />
2:45 p.m. S31.008<br />
Perihematomal Edema Expansion Rate<br />
Predicts Functional Outcome in Deep<br />
Intracerebral Hemorrhage —Zachary<br />
Grunwald, Sebastian Urday, Lauren Beslow,<br />
Anastasia Vashkevich, Alison Ayres, Steven<br />
Greenberg, Joshua Goldstein, Thomas<br />
Battey, Marc Simard, Jonathan Rosand, W.<br />
Kimberly, Kevin Sheth<br />
S32: Neuroepidemiology<br />
1:00 p.m. Presentation of the Bruce S.<br />
Schoenberg International Award in<br />
Neuroepidemiology<br />
Sponsored by the American Academy<br />
of Neurology and endowed by<br />
GlaxoSmithKline, Inc.<br />
Recipient:<br />
Rufus O. Akinyemi, MBBS, PhD,<br />
MWACP, FMCP<br />
Ibadan, Nigeria<br />
1:30 p.m. S32.003<br />
Quantification of Risks of Seizure in<br />
Autism —Jennifer Jaskiewicz, Apryl Susi,<br />
Elizabeth Hisle-Gorman, David Dennison,<br />
Gregory Gorman, Cade Nylund, Christine<br />
Erdie-Lalena<br />
1:45 p.m. S32.004<br />
Polychlorinated Biphenyls (PCBs)<br />
and Parkinson's Disease (PD): Effect<br />
Modification by Membrane Transporter<br />
Variants —Samuel Goldman, Freya Kamel,<br />
Chen Meng, Monica Korell, Kathleen<br />
Comyns, David Umbach, Jane Hoppin,<br />
G. Ross, Connie Marras, Meike Kasten,<br />
Anabel Chade, Aaron Blair, Caroline Tanner<br />
2:00 p.m. S32.005<br />
A Prospective Comorbidity-Matched<br />
Study of Parkinson's Disease and the<br />
Risk of Mortality Among Women —<br />
Pamela Rist, Anke Winter, Julie Buring,<br />
Tobias Kurth<br />
2:15 p.m. S32.006<br />
Adherence to Ideal Cardiovascular<br />
Health Guidelines Prevents Vascular<br />
Brain Injury, Dementia and Cognitive<br />
Decline —Matthew Pase, Alexa Beiser,<br />
Danielle Enserro, Vanessa Xanthakis,<br />
Hugo Javier Aparicio, Claudia Satizabal,<br />
Jayandra Himali, Carlos Kase, Vasan<br />
Ramachandran, Charles DeCarli, Sudha<br />
Seshadri<br />
2:30 p.m. S32.007<br />
Temporal Trends in Stroke Incidence<br />
in the Young in the Framingham<br />
Study —Hugo Javier Aparicio, Alexa<br />
Beiser, Jayandra Himali, Claudia Satizabal,<br />
Matthew Pase, Jose Romero, Carlos Kase,<br />
Sudha Seshadri<br />
2:45 p.m. S32.008<br />
Daylight Saving Time Transitions,<br />
Incidence and In-Hospital Mortality of<br />
Ischemic Stroke —Jussi O. Sipilä, Jori<br />
Ruuskanen, Päivi Rautava, Ville Kytö<br />
1:00 p.m.–3:00 p.m. Section Topic Controversies<br />
S33 Section Topic Controversies: Autoimmune/Paraneoplastic Neurological Disorders:<br />
Update on Imaging and Antibody Testing<br />
Director: Sean J. Pittock, MD<br />
1:00 p.m.–1:15 p.m. Introduction<br />
Sean J. Pittock, MD<br />
1:15 p.m.–2:00 p.m.<br />
Neural Autoantibody Evaluations: Looking Toward the Future<br />
Andrew McKeon, MD<br />
2:00 p.m.–2:45 p.m.<br />
Update on Body and Nervous System Imaging in Autoimmune<br />
Neurological Disorders<br />
Jenny Linnoila, MD, PhD<br />
2:45 p.m.–3.00 p.m.<br />
Questions and Answers<br />
102 2016 AAN Annual Meeting Abstract Listing
Change language